Tag archive for ‘MG01CI (Metadoxine extended-release)’
Globes On Sunday, October 27th, 2013

Alcobra Raises $33 Million In Secondary Nasdaq Offering

– The ADHD treatment developer raised $27 million in its IPO in May. –     Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD) raised a gross $33 million in its secondary offering on Thursday. More...

Wordpress site Developed by Fixing WordPress Problems